News|Articles|November 7, 2025

AJMC® in the Press, November 7, 2025

Fact checked by: Maggie L. Shaw
Listen
0:00 / 0:00

Key Takeaways

  • Syndromic real-time PCR tests for respiratory infections provide economic advantages by improving healthcare utilization and reducing costs.
  • The potential end of ACA premium subsidies in 2026 could significantly increase insurance costs for affected individuals.
SHOW MORE

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

An article published in Becker’s Hospital Review referenced a study published in the September 2025 issue of The American Journal of Managed Care® (AJMC®). The study, “Health Care Utilization and Cost of Diagnostic Testing for Respiratory Infections,” highlighted the advantages of syndromic real-time polymerase chain reaction tests for respiratory infections when it comes to their economic impact.

An article from TheStreet referenced an article published on AJMC.com, the website of AJMC. The article, “5 Consequences If ACA Premium Subsidies End in 2026,” highlighted the immediate effects of the expiration of the subsidies included in the Affordable Care Act (ACA), which could drive up the cost of insurance for those covered by these plans.

An article from AJMC entitled, “Microplastics May Play Role in Idiopathic Pulmonary Fibrosis,” was referenced in an article from The Cooldown. The article from AJMC reported on findings that prolonged exposure to microplastics was associated with pulmonary interstitial fibrosis and could exacerbate idiopathic pulmonary fibrosis due to oxidative stress, inflammation of pulmonary cells, and mitochondrial damage.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.


Latest CME

Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo